Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Self-assembled mirror DNA nanostructures for tumor-specific delivery of anticancer drugs.

Kim KR, Kim HY, Lee YD, Ha JS, Kang JH, Jeong H, Bang D, Ko YT, Kim S, Lee H, Ahn DR.

J Control Release. 2016 Dec 10;243:121-131. doi: 10.1016/j.jconrel.2016.10.015. Epub 2016 Oct 14.

PMID:
27746274
2.

Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.

Xie Q, Deng W, Yuan X, Wang H, Ma Z, Wu B, Zhang X.

Eur J Pharm Biopharm. 2018 Jan;122:87-95. doi: 10.1016/j.ejpb.2017.10.010. Epub 2017 Oct 13.

PMID:
29032193
3.

Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.

Xiang J, Wu B, Zhou Z, Hu S, Piao Y, Zhou Q, Wang G, Tang J, Liu X, Shen Y.

Sci China Life Sci. 2018 Apr;61(4):436-447. doi: 10.1007/s11427-017-9274-9. Epub 2018 Mar 19.

PMID:
29572777
4.

RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.

Baek SE, Lee KH, Park YS, Oh DK, Oh S, Kim KS, Kim DE.

J Control Release. 2014 Dec 28;196:234-42. doi: 10.1016/j.jconrel.2014.10.018. Epub 2014 Oct 24.

PMID:
25450401
5.

Structure-directing star-shaped block copolymers: supramolecular vesicles for the delivery of anticancer drugs.

Yang C, Liu SQ, Venkataraman S, Gao SJ, Ke X, Chia XT, Hedrick JL, Yang YY.

J Control Release. 2015 Jun 28;208:93-105. doi: 10.1016/j.jconrel.2015.03.027. Epub 2015 Mar 23.

PMID:
25813888
6.

Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.

Teymouri M, Badiee A, Golmohammadzadeh S, Sadri K, Akhtari J, Mellat M, Nikpoor AR, Jaafari MR.

Int J Pharm. 2016 Sep 10;511(1):236-244. doi: 10.1016/j.ijpharm.2016.06.117. Epub 2016 Jun 27.

PMID:
27363937
7.

Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy.

Pasut G, Paolino D, Celia C, Mero A, Joseph AS, Wolfram J, Cosco D, Schiavon O, Shen H, Fresta M.

J Control Release. 2015 Feb 10;199:106-13. doi: 10.1016/j.jconrel.2014.12.008. Epub 2014 Dec 9.

8.

Efficacy, biodistribution, and pharmacokinetics of CD22-targeted pegylated liposomal doxorubicin in a B-cell non-Hodgkin's lymphoma xenograft mouse model.

Tuscano JM, Martin SM, Ma Y, Zamboni W, O'Donnell RT.

Clin Cancer Res. 2010 May 15;16(10):2760-8. doi: 10.1158/1078-0432.CCR-09-3199. Epub 2010 May 11.

9.

Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration.

Riviere K, Huang Z, Jerger K, Macaraeg N, Szoka FC Jr.

J Drug Target. 2011 Jan;19(1):14-24. doi: 10.3109/10611861003733953. Epub 2010 Mar 30.

10.

Fabrication of Polymeric Micelles with Aggregation-Induced Emission and Forster Resonance Energy Transfer for Anticancer Drug Delivery.

Hao N, Sun C, Wu Z, Xu L, Gao W, Cao J, Li L, He B.

Bioconjug Chem. 2017 Jul 19;28(7):1944-1954. doi: 10.1021/acs.bioconjchem.7b00274. Epub 2017 Jun 15.

PMID:
28570043
12.

Novel drug delivery liposomes targeted with a fully human anti-VEGF165 monoclonal antibody show superior antitumor efficacy in vivo.

Shi C, Cao H, He W, Gao F, Liu Y, Yin L.

Biomed Pharmacother. 2015 Jul;73:48-57. doi: 10.1016/j.biopha.2015.05.008. Epub 2015 May 30.

PMID:
26211582
13.

Orthogonally functionalized nanoscale micelles for active targeted codelivery of methotrexate and mitomycin C with synergistic anticancer effect.

Li Y, Lin J, Wu H, Chang Y, Yuan C, Liu C, Wang S, Hou Z, Dai L.

Mol Pharm. 2015 Mar 2;12(3):769-82. doi: 10.1021/mp5006068. Epub 2015 Feb 5.

PMID:
25625539
14.

A novel size-tunable nanocarrier system for targeted anticancer drug delivery.

Li Y, Xiao K, Luo J, Lee J, Pan S, Lam KS.

J Control Release. 2010 Jun 15;144(3):314-23. doi: 10.1016/j.jconrel.2010.02.027. Epub 2010 Mar 6.

15.

Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods.

Agarwal A, Mackey MA, El-Sayed MA, Bellamkonda RV.

ACS Nano. 2011 Jun 28;5(6):4919-26. doi: 10.1021/nn201010q. Epub 2011 Jun 2.

PMID:
21591812
16.

DNA origami as an in vivo drug delivery vehicle for cancer therapy.

Zhang Q, Jiang Q, Li N, Dai L, Liu Q, Song L, Wang J, Li Y, Tian J, Ding B, Du Y.

ACS Nano. 2014 Jul 22;8(7):6633-43. doi: 10.1021/nn502058j. Epub 2014 Jun 30.

PMID:
24963790
17.

Cationic drug-based self-assembled polyelectrolyte complex micelles: Physicochemical, pharmacokinetic, and anticancer activity analysis.

Ramasamy T, Poudel BK, Ruttala H, Choi JY, Hieu TD, Umadevi K, Youn YS, Choi HG, Yong CS, Kim JO.

Colloids Surf B Biointerfaces. 2016 Oct 1;146:152-60. doi: 10.1016/j.colsurfb.2016.06.004. Epub 2016 Jun 5.

PMID:
27318960
18.

pH-responsive polymer-liposomes for intracellular drug delivery and tumor extracellular matrix switched-on targeted cancer therapy.

Chiang YT, Lo CL.

Biomaterials. 2014 Jul;35(20):5414-5424. doi: 10.1016/j.biomaterials.2014.03.046. Epub 2014 Apr 4.

PMID:
24709521
19.

An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery.

Ding Y, Sun D, Wang GL, Yang HG, Xu HF, Chen JH, Xie Y, Wang ZQ.

Int J Nanomedicine. 2015 Oct 1;10:6199-214. doi: 10.2147/IJN.S92519. eCollection 2015.

20.

The effect of dual-functional hyaluronic acid-vitamin E succinate micelles on targeting delivery of doxorubicin.

Wang J, Ma W, Guo Q, Li Y, Hu Z, Zhu Z, Wang X, Zhao Y, Chai X, Tu P.

Int J Nanomedicine. 2016 Nov 7;11:5851-5870. eCollection 2016.

Supplemental Content

Support Center